Physician

Alan B Schlussel, O.D.

According to 2025 Medicare claims, Alan Schlussel, O.D. (NPI: 1538161740) practices optometrist in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is ALAN B SCHLUSSEL OD LLC (NPI: 1376123422; TIN: 862877893) and primary practice location at 07052-4204.

Schlussel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 205 traditional Medicare patients, billed 639 HCPCS/CPT codes, and received $35,367 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 213 prescription claims across 66 beneficiaries totaling $89,778 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 10 records totaling $1,454. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $56,894 and ending at $89,778. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$43K2015 Medicare payment: $40,677 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $42,802 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $32,443 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $35,732 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $29,964 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $20,651 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $28,353 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $31,011 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $33,885 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $35,367 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015188825$40,677
2016188740$42,802
2017165682$32,443
2018176686$35,732
2019161980$29,964
2020131307$20,651
2021161503$28,353
2022178492$31,011
2023201598$33,885
2024205639$35,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$47K$94K2015 Drug cost: $56,894 (USD; Tot_Drug_Cst)2016 Drug cost: $72,032 (USD; Tot_Drug_Cst)2017 Drug cost: $73,016 (USD; Tot_Drug_Cst)2018 Drug cost: $87,333 (USD; Tot_Drug_Cst)2019 Drug cost: $83,060 (USD; Tot_Drug_Cst)2020 Drug cost: $59,732 (USD; Tot_Drug_Cst)2021 Drug cost: $67,434 (USD; Tot_Drug_Cst)2022 Drug cost: $61,777 (USD; Tot_Drug_Cst)2023 Drug cost: $93,742 (USD; Tot_Drug_Cst)2024 Drug cost: $89,778 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201563249$56,894
201669262$72,032
201768254$73,016
201868260$87,333
201962238$83,060
202052162$59,732
202163228$67,434
202269183$61,777
202365214$93,742
202466213$89,778

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system110115$100
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3446$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5484$68
92250Photography of the retina129135$30
92145Measurement of corneal pressure2237$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast271,110$25,016
MieboPerfluorohexyloctane/Pf17750$17,617
CequaCyclosporine11630$12,333
CyclosporineCyclosporine221,080$7,448
Loteprednol EtabonateLoteprednol Etabonate18780$3,931

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$1,454Lumenis BE inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan B. Schlussel, O.D.?

Tedicare shows public-source Medicare data for Alan B. Schlussel, O.D. (NPI 1538161740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan B. Schlussel, O.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan B. Schlussel, O.D.?

Alan B. Schlussel, O.D. is linked to ALAN B SCHLUSSEL OD LLC (billing NPI 1376123422) in the available physician profile data.

Does Alan B. Schlussel, O.D. have Open Payments data?

Alan B. Schlussel, O.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.